 SOMERSET, N.J.--BUSINESS WIRE--Catalent, Inc. NYSE: CTLT, the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will participate at two upcoming investor conferences. On September 13, 2022 at 11:45 a.m. ET, the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference. On September 1 